About Cambrium
Cambrium is a Healthcare company based in Berlin (Germany) founded in 2020. Protein-based biomaterials for skin applications are developed and provided. It operates on a AI-as-a-Service and B2B2C model. Cambrium has raised $8.47 million across 3 funding rounds from investors including Earth Venture Capital, Gradient Ventures and Essential Capital. Cambrium offers products and services including Supermolecules™ and NovaColl™. Its focus areas include Chemicals, Specialty Chemicals and Advanced Materials. Its legal entity is Cambrium GmbH.
Company details
Cambrium is engaged in the development of advanced molecules termed Supermolecules, created through AI-driven molecular design technology. These molecules are manufactured to outperform traditional materials, offering improved performance and seamless integration into industrial processes. The company targets sectors like personal care with products such as skin-identical vegan collagen. Solutions are tailored to address material challenges, enabling sustainable and innovative products for people and the planet. Local feedstocks are utilized to manufacture close to customers, enhancing resilience.
- Headquarters Berlin, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cambrium.bio
- Social LinkedIn X Instagram
- Legal Name Cambrium Gmbh
- Total Equity Funding$8.47M (USD)
in 3 rounds
- InvestorsEarth Venture Capital
& 6 more
Products & Services of Cambrium
Cambrium offers a comprehensive portfolio of products and services, including Supermolecules™ and NovaColl™.
Novel material blocks with unique functionalities are created.
Skin-identical vegan collagen for personal care is provided.
Funding Insights of Cambrium
Cambrium has successfully raised a total of $8.47M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.47M
- Total Rounds 3
- First Round $8.47M
(Oct 2023)
- Investors Count 7
All 3 funding rounds of Cambrium with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | Seed | – | – | ||
| Nov 2024 | Seed | – | Earth Venture Capital | ||
| Oct 2023 | $8.47M | Seed | – | Essential Capital |
7 investors in total: 7 institutional.
Investors in Cambrium
Cambrium has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Earth Venture Capital, Gradient Ventures and Essential Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| earth.vc | ||||
Venture capital arm of Alphabet Inc. investing in AI | gradient.com | Mountain View, United States | ||
Essential Capital is associated with financial services or investments. | essential.capital | |||
Venture capital investments are provided to startups by SNR Ventures. | snr.vc | |||
Private equity firm | valorep.com | Chicago, United States | ||
HOF Capital is engaged in venture capital investments. | hofcapital.com | New York, United States | ||
| redstone.vc |
Investor details for Cambrium
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cambrium
14 people are tracked at Cambrium (3 in leadership, 11 in team).
| Name | Role | Group |
|---|---|---|
Mitchell Duffy | Chief Executive Officer | Leadership |
Charlie Cotton, PhD | Chief Scientific Officer | Leadership |
Pierre Salvy | Chief Technology Officer | Leadership |
Dylan Vaughan | Senior Bioprocessing Scientist | Team |
Felix Tobias Schröter | Scientific Computing | Team |
Sebastian Rämisch | Protein Designer | Team |
Sam Tadman | Polymers Lead | Team |
Sanne van Doorn | Scientist | Team |
Fernando Garcés Daza | Strain Engineer | Team |
Timur Sander | Research & Development Lead | Team |
Aron Rogmann | Automation Engineer | Team |
Ozan Gemikonakli | Protein Data Scientist | Team |
Aníbal Mora | Senior Bioprocess Engineer | Team |
Jaqueline Hess | Engineering Lead | Team |
Complete people profiles for Cambrium
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cambrium
3 dated milestones of Cambrium across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cambrium is founded.
- Funding First funding round of $8.5M.
- Funding Latest funding round, Seed,.
Web traffic of Cambrium
The website of Cambrium (cambrium.bio) receives about 2K visits a month.
- Monthly visits2K
▼ 32.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cambrium
Complete news archive for Cambrium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cambrium
Cambrium was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Cambrium is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Cambrium is a funded company, having raised a total of $8.47M across 3 funding rounds to date. The company's 1st funding round was a Seed of $8.47M, raised on Oct 2023.
Cambrium is engaged in the development of advanced molecules termed Supermolecules, created through AI-driven molecular design technology. These molecules are manufactured to outperform traditional materials, offering improved performance and seamless integration into industrial processes. The company targets sectors like personal care with products such as skin-identical vegan collagen. Solutions are tailored to address material challenges, enabling sustainable and innovative products for people and the planet. Local feedstocks are utilized to manufacture close to customers, enhancing resilience.
Cambrium offers Supermolecules™ and NovaColl™.
Cambrium has 7 investors. Key investors include Earth Venture Capital, Gradient Ventures, Essential Capital, SNR Ventures, and Valor Equity Partners.
Cambrium operates through Cambrium Gmbh.